In April 13th, New Coronavirus’s SARS-CoV-2 ( Sansure Biotech Inc(688289) ) rapid antigen detection kit (immunochromatography) self testing product was granted the EU CE entry qualification. This means that the self-test kit can be sold in EU countries and countries that recognize EU CE certification.
According to the introduction, Sansure Biotech Inc(688289) covid-19 rapid antigen detection reagent self-test product is simple and fast without detection equipment. Individuals can collect nasal swabs for operation and produce results in 15-20 minutes, which is convenient for individuals and families to carry out rapid detection of covid-19 virus.
Sansure Biotech Inc(688289) said that the company’s covid-19 rapid antigen detection reagent self-test product has obtained the EU ce1434 self-test certificate, indicating that the performance of the company’s immune detection products has been recognized by the official institutions, further enriching the company’s whole scene covid-19 detection solution, expanding and meeting the detection and prevention needs of the global market at all levels, and continuously contributing to the global epidemic prevention and control.
